Wikipedia -WSS

Wikipedia

author：focus 2025-09-06 01:55:22 - browse：74391

Mel Evans/AP

Merck announced Monday it will acquire Harpoon Therapeutics and its pipeline of immune-based cancer drugs for $680 million. Merck will pay $23 per share, just over twice Harpoon’s market price entering the week.

The bolt-on deal comes as Merck’s top brass searches for ways to bolster the company’s revenue after it loses exclusivity on Keytruda, long the world’s most lucrative cancer drug. That could come as soon as 2028.

Keytruda, a PD-(L)1 inhibitor, works by turning off a “brake” on T cells, allowing roving immune cells to attack tumors. Harpoon’s pipeline belongs to a new class of cancer drugs designed to grab onto the T cells and tumor cells and bring them together.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： Researchers on aging grapple with how to calculate biological age

WSS

Cherokee Nation medical school graduates its first class

Readout Newsletter: Sanofi, Novavax, Maze x Shionogi news

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

Hottest summer in 2,000 years puts focus on extreme heat, health

Use wet bulb globe temperature, not heat index, to protect workers

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

hotspot

Wikipedia

explore

Peter Hotez and the public health issue of online harassment

What nurses really want: sufficient staffing for patient care

As demand for Covid shots wanes, Moderna seeks its next success

How to improve immunocompromised access to mAb treatments

Moonlake's readout produced a cash windfall. Risks remain

Medicare says breakthrough device reimbursement rule to come by summer

The cancer drug shortage isn’t new — and neither are the solutions

Ripples from Flovent's discontinuation is killing children with asthma

After affirmative action ruling, medical educators look to 'holistic review'

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

explore

Oak Street deal isn't the answer to health care's woes

Readout Newsletter: Raw milk, Wegovy tests, Eisai and Biogen

The White House hikes tariffs on plastic syringes made in China

Readout LOUD podcast: brain research, obesity drug sales, Novartis

Dairy farmers resist CDC push for PPE against bird flu virus

H5N1 bird flu: what we're starting to learn about infection in cows

knowledge

leisure time

Wikipedia

knowledge